Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126059621 | 12605962 | 1 | I | 20150826 | 0 | 20160728 | 20160728 | DIR | 60.00 | YR | F | N | 0.00000 | 20160727 | N | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126059621 | 12605962 | 1 | PS | LEVAQUIN | LEVOFLOXACIN | 1 | Oral | N | D | 0 | |||||||||
| 126059621 | 12605962 | 3 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | 0 | ||||||||||||
| 126059621 | 12605962 | 5 | C | BENICAR | OLMESARTAN MEDOXOMIL | 1 | 0 | ||||||||||||
| 126059621 | 12605962 | 7 | C | CALCIUM/VIT D | 2 | 0 | |||||||||||||
| 126059621 | 12605962 | 9 | C | CANASA SUPP | 2 | 0 | |||||||||||||
| 126059621 | 12605962 | 11 | C | CLONAZEPAM. | CLONAZEPAM | 1 | 0 | ||||||||||||
| 126059621 | 12605962 | 13 | C | CODEINE SULFATE. | CODEINE SULFATE | 1 | 0 | ||||||||||||
| 126059621 | 12605962 | 15 | C | DULERA | FORMOTEROL FUMARATE DIHYDRATEMOMETASONE FUROATE | 1 | 0 | ||||||||||||
| 126059621 | 12605962 | 17 | C | NASOCORT AQUA | 2 | 0 | |||||||||||||
| 126059621 | 12605962 | 19 | C | OPANA ER | OXYMORPHONE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126059621 | 12605962 | 21 | C | PREDNISONE. | PREDNISONE | 1 | 0 | ||||||||||||
| 126059621 | 12605962 | 23 | C | PROZAC | FLUOXETINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126059621 | 12605962 | 25 | C | VAGI-FEM | 2 | 0 | |||||||||||||
| 126059621 | 12605962 | 27 | C | XALATAN | LATANOPROST | 1 | 0 | ||||||||||||
| 126059621 | 12605962 | 28 | SS | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 126059621 | 12605962 | 30 | C | FORTEO | TERIPARATIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126059621 | 12605962 | 1 | Staphylococcal infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126059621 | 12605962 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126059621 | 12605962 | Alopecia | |
| 126059621 | 12605962 | Anaemia | |
| 126059621 | 12605962 | Balance disorder | |
| 126059621 | 12605962 | Deep vein thrombosis | |
| 126059621 | 12605962 | Dyspnoea | |
| 126059621 | 12605962 | Gait disturbance | |
| 126059621 | 12605962 | Internal haemorrhage | |
| 126059621 | 12605962 | Musculoskeletal stiffness | |
| 126059621 | 12605962 | Nerve injury | |
| 126059621 | 12605962 | Neuropathy peripheral | |
| 126059621 | 12605962 | Nightmare | |
| 126059621 | 12605962 | Quality of life decreased | |
| 126059621 | 12605962 | Tendon pain | |
| 126059621 | 12605962 | Tendon rupture |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126059621 | 12605962 | 1 | 20150822 | 20150824 | 0 |